PremiumThe FlyAchieve Life Sciences reports Q1 EPS (37c), consensus (37c) Is ACHV a Buy, Before Earnings? Achieve Life Sciences Receives Buy Rating Amid Promising Developments in Smoking Cessation Market PremiumThe FlyAchieve Life Sciences reports Q4 EPS (36c), consensus (36c) ACHV Upcoming Earnings Report: What to Expect? Promising Outlook for Achieve Life Sciences: Buy Rating Backed by Strong Trial Results and Market Potential PremiumCompany AnnouncementsAchieve Life Sciences Appoints Mark K. Oki as CFO Achieve Life Sciences appoints Oki as Chief Financial Officer Achieve Life Sciences announces outcome of End-of-Phase 2 meeting with FDA